Fertility preservation in gynecologic cancers.

Autor: Taylan E; Women's Cancer Program at Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Laboratory of Molecular Reproduction and Fertility Preservation, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. Electronic address: enes.taylan@cshs.org., Oktay K; Laboratory of Molecular Reproduction and Fertility Preservation, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA; Innovation Institute for Fertility Preservation and IVF, New York, NY, USA; Ovarian Transplantation Program, NYU Winthrop Hospital, Mineola, NY, USA.
Jazyk: angličtina
Zdroj: Gynecologic oncology [Gynecol Oncol] 2019 Dec; Vol. 155 (3), pp. 522-529. Date of Electronic Publication: 2019 Oct 08.
DOI: 10.1016/j.ygyno.2019.09.012
Abstrakt: An increasing number of women in modern societies are delaying childbearing beyond the age of 35, and gynecologic cancers affect a significant proportion of reproductive age women who wish to preserve fertility for a future chance of childbearing. As a result, providing treatment options for fertility preservation in women with gynecologic cancer has become a crucial component of cancer survivorship care. In this review article, we discussed the current knowledge on fertility-sparing surgical approaches, as well as assisted reproductive technologies that can be utilized to preserve reproductive potential in women with cervical, endometrial, and ovarian cancer. A brief section on fertility preservation in pediatric gynecologic malignancies is also provided.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: